Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04692337 · ClinicalTrials.gov registry record · NA
Ommaya Reservoir Placement for Brain Tumor Biomarker Access
A NA study of Brain Tumor, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04692337: Recruiting NA study of Brain Tumor, sponsored by Mayo Clinic.
NCT04692337 is a NA study of Brain Tumor that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 280-participant average among 69 other Brain Tumor trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04692337, a NA study of Brain Tumor, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the safety and feasibility of intra-operative Ommaya Reservoir placement during a clinically indicated operation for brain tumor. The Ommaya reservoir will facilitate a longitudinal access to cerebrospinal fluid (CSF) for analysis of potential biomarkers for brain tumor research and individualized monitoring.
Primary Outcome
Assessed by the proportion of patients for whom longitudinal CSF can be collected.
Conditions Studied
Interventions
- PROCEDURE Intra-operative Ommaya Reservoir placement
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-01-15 |
| Est. Completion | 2027-02-28 |
| Phase | NA |
What NCT04692337 shows while recruiting
NCT04692337 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 280-participant average among 69 other Brain Tumor trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which Intra-operative Ommaya Reservoir placement is the first listed.
NCT04692337 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04692337 about?
NCT04692337 is a clinical study titled "Ommaya Reservoir Placement for Brain Tumor Biomarker Access". The purpose of this study is to determine the safety and feasibility of intra-operative Ommaya Reservoir placement during a clinically indicated operation for brain tumor. The Ommaya reservoir will facilitate a longitudinal access to cerebrospinal fluid (CSF) for analysis of potential biomarkers for...
What is the current status of trial NCT04692337?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2021-01-15. Estimated completion is 2027-02-28.
What conditions does trial NCT04692337 study?
This clinical trial studies the following conditions: Brain Tumor.
What interventions are being tested in trial NCT04692337?
The interventions under investigation include: Intra-operative Ommaya Reservoir placement (PROCEDURE).
Who is sponsoring clinical trial NCT04692337?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04692337 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04692337's enrollment target sits among peer trials
100 18th of 69 higher than 51 of 69 other Brain Tumor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
RECRUITING · NA
-
Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors
RECRUITING · NA
-
Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption
RECRUITING · NA
-
Mapping of Human Cognition
RECRUITING · NA
-
LITT Followed by Hypofractionated RT for Recurrent Gliomas
RECRUITING · NA
-
Visual Plasticity Following Brain Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI